Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.47792 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44228 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44294 | 18 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.38558 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.38903 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.50948 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46018 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.41915 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.4051 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.42998 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.42417 | 18 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.40977 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.45154 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43631 | 18 |